These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 2706245

  • 1. Tryptophan fluorescence as a probe of placental ribonuclease inhibitor binding to angiogenin.
    Lee FS, Auld DS, Vallee BL.
    Biochemistry; 1989 Jan 10; 28(1):219-24. PubMed ID: 2706245
    [Abstract] [Full Text] [Related]

  • 2. Tight-binding inhibition of angiogenin and ribonuclease A by placental ribonuclease inhibitor.
    Lee FS, Shapiro R, Vallee BL.
    Biochemistry; 1989 Jan 10; 28(1):225-30. PubMed ID: 2706246
    [Abstract] [Full Text] [Related]

  • 3. Interaction of human placental ribonuclease with placental ribonuclease inhibitor.
    Shapiro R, Vallee BL.
    Biochemistry; 1991 Feb 26; 30(8):2246-55. PubMed ID: 1998683
    [Abstract] [Full Text] [Related]

  • 4. Binding of placental ribonuclease inhibitor to the active site of angiogenin.
    Lee FS, Vallee BL.
    Biochemistry; 1989 Apr 18; 28(8):3556-61. PubMed ID: 2742853
    [Abstract] [Full Text] [Related]

  • 5. Kinetic characterization of two active mutants of placental ribonuclease inhibitor that lack internal repeats.
    Lee FS, Vallee BL.
    Biochemistry; 1990 Jul 17; 29(28):6633-8. PubMed ID: 2397204
    [Abstract] [Full Text] [Related]

  • 6. Human placental ribonuclease inhibitor abolishes both angiogenic and ribonucleolytic activities of angiogenin.
    Shapiro R, Vallee BL.
    Proc Natl Acad Sci U S A; 1987 Apr 17; 84(8):2238-41. PubMed ID: 3470787
    [Abstract] [Full Text] [Related]

  • 7. Expression of human placental ribonuclease inhibitor in Escherichia coli.
    Lee FS, Vallee BL.
    Biochem Biophys Res Commun; 1989 Apr 14; 160(1):115-20. PubMed ID: 2653313
    [Abstract] [Full Text] [Related]

  • 8. Isolation of bovine angiogenin using a placental ribonuclease inhibitor binding assay.
    Bond MD, Vallee BL.
    Biochemistry; 1988 Aug 23; 27(17):6282-7. PubMed ID: 3064806
    [Abstract] [Full Text] [Related]

  • 9. Analysis of the interactions of human ribonuclease inhibitor with angiogenin and ribonuclease A by mutagenesis: importance of inhibitor residues inside versus outside the C-terminal "hot spot".
    Shapiro R, Ruiz-Gutierrez M, Chen CZ.
    J Mol Biol; 2000 Sep 15; 302(2):497-519. PubMed ID: 10970748
    [Abstract] [Full Text] [Related]

  • 10. Enzymatically active angiogenin/ribonuclease A hybrids formed by peptide interchange.
    Harper JW, Auld DS, Riordan JF, Vallee BL.
    Biochemistry; 1988 Jan 12; 27(1):219-26. PubMed ID: 3349027
    [Abstract] [Full Text] [Related]

  • 11. An in vitro binding assay for angiogenin using placental ribonuclease inhibitor.
    Bond MD.
    Anal Biochem; 1988 Aug 15; 173(1):166-73. PubMed ID: 3189795
    [Abstract] [Full Text] [Related]

  • 12. Site-directed mutagenesis of histidine-13 and histidine-114 of human angiogenin. Alanine derivatives inhibit angiogenin-induced angiogenesis.
    Shapiro R, Vallee BL.
    Biochemistry; 1989 Sep 05; 28(18):7401-8. PubMed ID: 2479414
    [Abstract] [Full Text] [Related]

  • 13. Specific binding of angiogenin to calf pulmonary artery endothelial cells.
    Badet J, Soncin F, Guitton JD, Lamare O, Cartwright T, Barritault D.
    Proc Natl Acad Sci U S A; 1989 Nov 05; 86(21):8427-31. PubMed ID: 2813401
    [Abstract] [Full Text] [Related]

  • 14. Modular mutagenesis of human placental ribonuclease inhibitor, a protein with leucine-rich repeats.
    Lee FS, Vallee BL.
    Proc Natl Acad Sci U S A; 1990 Mar 05; 87(5):1879-83. PubMed ID: 2408043
    [Abstract] [Full Text] [Related]

  • 15. Superadditive and subadditive effects of "hot spot" mutations within the interfaces of placental ribonuclease inhibitor with angiogenin and ribonuclease A.
    Chen CZ, Shapiro R.
    Biochemistry; 1999 Jul 20; 38(29):9273-85. PubMed ID: 10413501
    [Abstract] [Full Text] [Related]

  • 16. Site-specific mutagenesis reveals differences in the structural bases for tight binding of RNase inhibitor to angiogenin and RNase A.
    Chen CZ, Shapiro R.
    Proc Natl Acad Sci U S A; 1997 Mar 04; 94(5):1761-6. PubMed ID: 9050852
    [Abstract] [Full Text] [Related]

  • 17. Role of lysines in human angiogenin: chemical modification and site-directed mutagenesis.
    Shapiro R, Fox EA, Riordan JF.
    Biochemistry; 1989 Feb 21; 28(4):1726-32. PubMed ID: 2497770
    [Abstract] [Full Text] [Related]

  • 18. Characterization of the tryptophan residues of human placental ribonuclease inhibitor and its complex with bovine pancreatic ribonuclease A by steady-state and time-resolved emission spectroscopy.
    Sardar PS, Maity SS, Ghosh S, Chatterjee J, Maiti TK, Dasgupta S.
    J Phys Chem B; 2006 Oct 26; 110(42):21349-56. PubMed ID: 17048964
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of human pancreatic ribonuclease by the human ribonuclease inhibitor protein.
    Johnson RJ, McCoy JG, Bingman CA, Phillips GN, Raines RT.
    J Mol Biol; 2007 Apr 27; 368(2):434-49. PubMed ID: 17350650
    [Abstract] [Full Text] [Related]

  • 20. Angiogenin interacts with ribonuclease inhibitor regulating PI3K/AKT/mTOR signaling pathway in bladder cancer cells.
    Peng Y, Li L, Huang M, Duan C, Zhang L, Chen J.
    Cell Signal; 2014 Dec 27; 26(12):2782-92. PubMed ID: 25193113
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.